Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Nikpour M, Hissaria P, Byron J, Sahhar J, Micallef M, Paspaliaris W, Roddy J, Nash P, Sturgess A, Proudman S, Stevens W.

Arthritis Res Ther. 2011;13(6):R211. doi: 10.1186/ar3544. Epub 2011 Dec 22.

PMID:
22189167
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.

Ceribelli A, Krzyszczak ME, Li Y, Ross SJ, Chan JY, Chan EK, Burlingame RW, Webb TT, Bubb MR, Sobel ES, Reeves WH, Satoh M.

Arthritis Res Ther. 2011 Jul 22;13(4):R119. doi: 10.1186/ar3422.

PMID:
21781293
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.

Airo' P, Ceribelli A, Cavazzana I, Taraborelli M, Zingarelli S, Franceschini F.

J Rheumatol. 2011 Jul;38(7):1329-34. doi: 10.3899/jrheum.101144. Epub 2011 Apr 1.

PMID:
21459934
[PubMed - indexed for MEDLINE]
4.

Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.

Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P, Hayem G, Palazzo E, Chollet-Martin S, Kahan A, Allanore Y.

J Rheumatol. 2010 Jan;37(1):125-30. doi: 10.3899/jrheum.090677. Epub 2009 Nov 16.

PMID:
19918031
[PubMed - indexed for MEDLINE]
5.

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ.

J Rheumatol. 2007 Jul;34(7):1528-34. Epub 2007 Jun 15.

PMID:
17610318
[PubMed - indexed for MEDLINE]
6.

Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.

Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA Jr.

Arthritis Rheum. 2005 Aug;52(8):2425-32.

PMID:
16052583
[PubMed - indexed for MEDLINE]
Free Article
7.

Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis.

Sobanski V, Dauchet L, Lefèvre G, Lambert M, Morell-Dubois S, Sy T, Hachulla E, Hatron PY, Launay D, Dubucquoi S.

Arthritis Rheumatol. 2014 Feb;66(2):407-17. doi: 10.1002/art.38219. Review.

PMID:
24504813
[PubMed - indexed for MEDLINE]
8.

Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.

Chang M, Wang RJ, Yangco DT, Sharp GC, Komatireddy GR, Hoffman RW.

Clin Immunol Immunopathol. 1998 Oct;89(1):71-8.

PMID:
9756726
[PubMed - indexed for MEDLINE]
9.

Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.

Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M.

Rheumatology (Oxford). 2009 Dec;48(12):1570-4. doi: 10.1093/rheumatology/kep290. Epub 2009 Oct 5.

PMID:
19808694
[PubMed - indexed for MEDLINE]
Free Article
10.

Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.

Faucher B, Stein P, Granel B, Weiller PJ, Disdier P, Serratrice J, Harlé JR, Durand JM, Frances Y, Guis S, Pham T, Bardin N, Sanmarco M.

Eur J Intern Med. 2010 Apr;21(2):114-7. doi: 10.1016/j.ejim.2010.01.004. Epub 2010 Feb 8.

PMID:
20206882
[PubMed - indexed for MEDLINE]
11.

Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.

Satoh M, Vazquez-Del Mercado M, Krzyszczak ME, Li Y, Ceribelli A, Burlingame RW, Webb TT, Sobel ES, Reeves WH, Chan EK.

Lupus. 2012 Jan;21(1):68-74. doi: 10.1177/0961203311422712. Epub 2011 Oct 24.

PMID:
22025191
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.

Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ.

Clin Exp Immunol. 1999 Aug;117(2):395-402.

PMID:
10444276
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.

Cavazzana I, Ceribelli A, Airo' P, Zingarelli S, Tincani A, Franceschini F.

Autoimmun Rev. 2009 Jun;8(7):580-4. doi: 10.1016/j.autrev.2009.02.002. Epub 2009 Feb 9. Erratum in: Autoimmun Rev. 2013 Jan;12(3):457. Angela, Ceribelli [corrected to Ceribelli, Angela]; Paolo, Airo' [corrected to Airo', Paolo]; Stefania, Zingarelli [corrected to Zingarelli, Stefania]; Angela, Tincani [corrected to Tincani, Angela]; Franco, Franceschini [corrected to Franceschini, Franco].

PMID:
19393210
[PubMed - indexed for MEDLINE]
14.

Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.

Hesselstrand R, Scheja A, Wuttge DM.

Scand J Rheumatol. 2012 Feb;41(1):39-43. doi: 10.3109/03009742.2011.610032. Epub 2011 Nov 1.

PMID:
22044051
[PubMed - indexed for MEDLINE]
15.

A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.

Kang EH, Im CH, Kim SH, Chung JR, Lee EY, Kim DJ, Lee EB, Song YW.

J Korean Med Sci. 2006 Dec;21(6):1121-3.

PMID:
17179700
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.

Serologic profile and mortality rates of scleroderma renal crisis in Italy.

Codullo V, Cavazzana I, Bonino C, Alpini C, Cavagna L, Cozzi F, Del Papa N, Franceschini F, Guiducci S, Morozzi G, Ruffatti A, Ferri C, Giacomelli R, Matucci-Cerinic M, Valentini G, Montecucco C.

J Rheumatol. 2009 Jul;36(7):1464-9. doi: 10.3899/jrheum.080806. Epub 2009 Jun 1.

PMID:
19487262
[PubMed - indexed for MEDLINE]
18.

HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.

Nguyen B, Mayes MD, Arnett FC, del Junco D, Reveille JD, Gonzalez EB, Draeger HT, Perry M, Hendiani A, Anand KK, Assassi S.

Arthritis Rheum. 2011 Feb;63(2):530-4. doi: 10.1002/art.30111.

PMID:
21280007
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Anti-PM-Scl antibody in patients with systemic sclerosis.

Koschik RW 2nd, Fertig N, Lucas MR, Domsic RT, Medsger TA Jr.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S12-6. Epub 2012 May 29.

PMID:
22261302
[PubMed - indexed for MEDLINE]
20.

Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.

Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr.

J Rheumatol. 2007 Jan;34(1):104-9. Epub 2006 Nov 15.

PMID:
17117486
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk